Skip to main content
Blender Financial Technologies LTD logo

Blender Financial Technologies LTD — Investor Relations & Filings

Ticker · BLND ISIN · IL0011720971 LEI · 894500W3PS1DRDQS9972 TA Financial and insurance activities
Open in API
Filings indexed 23 across all filing types
Latest filing 2023-05-11 Regulatory Filings
Country IL Israel
Listing TA BLND

About Blender Financial Technologies LTD

https://blender.global/

Blender Financial Technologies LTD is a global financial technology company specializing in consumer credit and financing solutions. The company develops and operates a proprietary digital platform that provides a range of financial products, including personal loans, automotive financing, and point-of-sale (POS) payment solutions for both online and in-store purchases. Its technology leverages multiple data sources and advanced risk models to perform rapid credit assessments, typically within 30 seconds, enabling a simple, accessible, and paperless financing experience. The platform supports both direct-to-consumer (B2C) lending and business-to-business-to-consumer (B2B2C) financing partnerships.

Recent filings

Filing Released Lang Actions
Following the completion of its contracted two-year engagement under the Tel Aviv Stock Exchange Research Scheme, Frost and Sullivan Independent Equity Research is terminating coverage.
Regulatory Filings Classification · 95% confidence The document text is very short (324 characters) and announces the termination of an independent equity research coverage agreement under the Tel Aviv Stock Exchange Research Scheme. This is a specific, non-standard corporate announcement that does not fit clearly into the primary categories like 10-K, ER, or IR. Since it is a specific regulatory/market-related announcement that doesn't match the definitions for DVA, DLST, DIRS, DIV, etc., the most appropriate fallback category is Regulatory Filings (RNS), which covers general regulatory announcements that do not fit elsewhere.
2023-05-11 Hebrew (modern)
Following the completion of its contracted two-year engagement under the Tel Aviv Stock Exchange Research Scheme, Frost and Sullivan Independent Equity Research is terminating coverage.
Regulatory Filings Classification · 95% confidence The document text is very short (2749 characters) and contains structured fields typical of a regulatory filing cover page or summary, referencing an entity "FROST & SULLIVAN RESEARCH & CONSULTING LTD" and a date (11/05/2023). Crucially, near the end, it mentions: '��"� �������: *�����_�����_isa.pdf*', which strongly suggests that this document is an announcement or cover sheet pointing to an attached or linked report (the PDF file). Given the short length and the nature of pointing to a primary document, this fits the definition of a Report Publication Announcement (RPA) rather than the full report itself (like 10-K or IR).
2023-05-11 Russian
Analysis update following financial report- price target is updated to NIS 28.2
Regulatory Filings Classification · 99% confidence The document is titled 'INDEPENDENT EQUITY RESEARCH' and provides a detailed '2022 Financial Overview' including revenues, net loss, loan portfolio balance, and volume of loans made, covering the full fiscal year 2022. It also includes an 'Investment Thesis' and a 'Company Overview' with operational details. This structure, focusing on a full year's performance review and forward-looking analysis, strongly suggests it is an analyst report or initiation of coverage, rather than an official regulatory filing like a 10-K or an Earnings Release (ER). Since the definitions do not explicitly list 'Equity Research Report,' the closest fit among the provided options that covers comprehensive financial performance and analysis for a full year, often used by investors, is the Annual Report (10-K) if it were the official filing, or Investor Presentation (IP) if it were a slide deck. However, given the depth of financial review and the context of an analyst report, it functions similarly to a comprehensive review. Since it is explicitly an 'Equity Research' document, and not a formal company filing, it doesn't fit 10-K, IR, or ER. It is most similar in content scope to an Investor Presentation (IP) or a Management Discussion & Analysis (MDA) but is external research. Given the options, and recognizing that this is an external analysis summarizing annual results, it is best classified as an Investor Presentation (IP) as it presents investment rationale and financial data summaries, or potentially as a Regulatory Filing (RNS) if no better fit exists. Since it is a detailed analysis of the full year's performance (2022), it is more comprehensive than a typical Fund Factsheet (FS) or a simple Earnings Release (ER). Given the detailed financial summary and investment thesis, 'Investor Presentation' (IP) is the most appropriate category for this type of analytical document summarizing annual results, even though it is external research. Revisiting the definitions: It is not an official company filing (10-K, IR, ER). It is an analysis. IP is defined as 'Detailed presentation for investors focusing on financials, strategy, and market position.' This document fits that description perfectly, even if it's from a third party (Equity Research).
2023-04-04 English
Analysis update following financial report- price target is updated to NIS 28.2
Earnings Release Classification · 99% confidence The document text contains structured data, dates (e.g., 04/04/2023), company identifiers, and references to financial updates across several periods (e.g., '2022', '2021'). Crucially, it ends with a reference to a PDF file: '03042023_blender_q4_update_eng_isa.pdf'. This structure, combined with the short document length (3868 chars) and the explicit mention of a linked/attached report file, strongly suggests this is an announcement about the publication of a report rather than the report itself. Since it details updates across periods and references a specific file, it fits the definition of a Report Publication Announcement (RPA). It is not a full 10-K, a standard Earnings Release (ER), or a comprehensive Interim Report (IR), but rather the notice accompanying one of those reports. Q4 2022
2023-04-04 Russian
Analysis update - target price t is updated to NIS 26.2
Earnings Release Classification · 99% confidence The document is titled 'INDEPENDENT EQUITY RESEARCH' and provides a detailed update report on 'BLENDER FINANCIAL TECHNOLOGIES LTD.' dated 15.12.2022, focusing on Q3 2022 financial highlights, business strategy, market analysis, and an updated price target. This structure—a detailed analysis, financial review, and forward-looking commentary prepared by a third party (equity research firm)—is characteristic of an Investor Presentation (IP) or a detailed research report, rather than a mandatory regulatory filing like a 10-K or an ER. Since the document provides extensive analysis, investment thesis, and detailed operational metrics, it aligns best with the 'Investor Presentation' category, which covers detailed presentations for investors focusing on financials, strategy, and market position. Q3 2022
2022-12-15 English
Analysis update - target price t is updated to NIS 26.2
Management Reports Classification · 99% confidence The document text is highly fragmented and contains non-standard characters, suggesting it might be a poorly parsed or structured filing, possibly related to regulatory disclosure in Israel (indicated by Hebrew text and references like 'www.isa.gov.il'). Key elements include a date '15/12/2022', references to a company ('FROST & SULLIVAN RESEARCH & CONSULTING LTD'), and a filename that suggests a quarterly update ('blender_q3_update_eng_isa.pdf'). The structure involves tables and questions/answers typical of regulatory forms or disclosures. Given the presence of a specific file attachment reference and the nature of the content (which seems to be a formal submission rather than a general announcement), it is likely a specific regulatory filing. Since it references a Q3 update and is not a full annual report (10-K) or a standard interim report (IR) based on the structure, and it doesn't clearly fit other specific categories like DIRS, DIV, or CT, the most appropriate general category for a specific, non-standard regulatory document is 'Regulatory Filings' (RNS), or potentially an 'Interim Report' (IR) if the content were fully readable and confirmed to be a comprehensive financial statement. However, the presence of the explicit file name and the fragmented nature strongly suggest this is the *announcement* or wrapper document for the actual filing, making RPA or RNS more likely. Given the context of financial data presentation (tables with dates and values like '52.1', '26.2'), and the reference to an ISA (Israel Securities Authority) document, RNS (Regulatory Filings) is the best fit as a catch-all for specific regulatory disclosures that aren't standard quarterly/annual reports or management discussions.
2022-12-15 Russian

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.